Details of the Drug Reposition

General Information of This Drug (ID: DM3M9OY)

Drug Name
Anti-CD19/20-CAR vector-transduced T cells   DM3M9OY
Drug Type
CAR T Cell Therapy

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
4 Clinical trial Indication(s)
Indication Name Indication ID ICD-11 Status REF
Follicular lymphoma DISVEUR6 2A80 Clinical trial [1]
Diffuse large B-cell lymphoma DISSACK3 2A81 Clinical trial [1]
B-cell chronic lymphocytic leukaemia DISNHN2M 2A82.00 Clinical trial [1]
Acute lymphoblastic leukaemia DIS87TGM 2A85 Clinical trial [1]
------------------------------------------------------------------------------------

References

1 ClinicalTrials.gov (NCT03097770) Treatment of Relapsed and/or Chemotherapy Refractory B-cell Malignancy by Tandem CAR T Cells Targeting CD19 and CD20